Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle

Completed · Not applicable

Conditions studied: Pancreatic Cancer

In brief

This is a clinical trial to compare two needles used in biopsy techniques to acquire tissue from pancreatic cancer. The hypothesis is that the tissue yield, as measured by tumor DNA and cellular material is superior for Flexible Needle Biopsy (FNB) compared with conventional Fine Needle Aspiration (FNA). Specifically, FNB will increase the proportion of cases in which sufficient DNA is obtained to allow genomic profiling and whole exome sequencing.

Key facts

Study ID

NCT02678442

Run by

Mayo Clinic

People needed

50

Starts

2016-05-16

Expected to finish

2018-11-10

Last updated by the study team

2020-01-06

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients who are 18 years old or older and are referred for the evaluation of pancreatic mass lesion.
• International Normalized Ratio (INR) less than 1.5 and platelet count of more than 50,000.
• Medically stable to undergo sedation for EUS.
• Signed informed consent

You may not qualify if…

• Medical condition that preclude the patient from having a therapeutic procedure regardless of the EUS finding
• Pregnant patients

Where it is running

• Mayo Clinic — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.